Rani Therapeutics Holdings, Inc.RANINASDAQ
Loading
R&D Expenses Over TimeContracting
Percentile Rank17
3Y CAGR-15.5%
5Y CAGR+12.9%
Year-over-Year Change
Research and development spending
3Y CAGR
-15.5%/yr
Annual compound
5Y CAGR
+12.9%/yr
Recent deceleration
Percentile
P17
Within normal range
vs 5Y Ago
1.8x
Solid growth
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $22.11M | -17.2% |
| 2024 | $26.68M | -32.7% |
| 2023 | $39.62M | +8.2% |
| 2022 | $36.61M | +38.2% |
| 2021 | $26.48M | +119.9% |
| 2020 | $12.04M | -51.0% |
| 2019 | $24.58M | - |